ClinicalTrials.Veeva

Menu

Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)

R

Region Skane

Status

Completed

Conditions

Urinary Tract Infection

Treatments

Device: Silicone Urinary Catheter
Device: Bactiguard Infection Protection (BIP) Cathter.

Study type

Interventional

Funder types

Other

Identifiers

NCT01054690
H15 315/2007

Details and patient eligibility

About

This study is a single blinded (Outcome Assessors), multicenter randomized controlled study designed to investigate if a silver alloyed urinary catheter with antibacterial properties can reduce the incidence of catheter acquired urinary tract infections in patients undergoing elective surgery. Patients requiring urinary catheterization will be randomized into two groups and receive either the silver alloyed catheter (test) or a silicone catheter (control).

Enrollment

511 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults in elective surgery requiring urinary catheterization

Exclusion criteria

  • Patients who has or recently (within 3 weeks) had a urinary catheter
  • Signs of urinary tracts infection
  • Previous radiation therapy in lower pelvis
  • Latex allergy
  • Cognitive impaired
  • Do not understand Swedish language.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

511 participants in 2 patient groups, including a placebo group

Silver alloyed urinary catheter
Experimental group
Treatment:
Device: Bactiguard Infection Protection (BIP) Cathter.
Silicone urinary catheter
Placebo Comparator group
Treatment:
Device: Silicone Urinary Catheter

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems